Strongbridge Biopharma PLC Operating Income 2016-2021 | SBBP
Strongbridge Biopharma PLC operating income from 2016 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Strongbridge Biopharma PLC Annual Operating Income (Millions of US $) |
|
|---|---|
| 2020 | $-43 |
| 2019 | $-67 |
| 2018 | $-82 |
| 2017 | $-74 |
| 2016 | $-51 |
| 2015 | $-43 |
| 2014 | $-10 |
| 2013 | $-5 |
| Strongbridge Biopharma PLC Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2021-06-30 | $-13 |
| 2021-03-31 | $-10 |
| 2020-12-31 | $-10 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-10 |
| 2020-03-31 | $-14 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-17 |
| 2019-06-30 | $-17 |
| 2019-03-31 | $-16 |
| 2018-12-31 | $-22 |
| 2018-09-30 | $-25 |
| 2018-06-30 | $-19 |
| 2018-03-31 | $-16 |
| 2017-12-31 | $-14 |
| 2017-09-30 | $-33 |
| 2017-06-30 | $-14 |
| 2017-03-31 | $-12 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-8 |
| 2016-06-30 | $-14 |
| 2016-03-31 | $-11 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-10 |
| 2015-06-30 | $-17 |
| 2015-03-31 | $-6 |
